Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Genomics|August 25, 2006
Intron length and accelerated 3' gene evolutionClara S Tang, Yong Z Zhao, David K Smith, et al.
Clinical Colorectal Cancer|April 10, 2010
Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic diseaseThomas Yau, Hilda Wong, Pierre Chan, et al.
Cancer Detection and Prevention|July 18, 2008
Evidence for a programming effect of early menarche on the rise of breast cancer incidence in Hong KongAmy W H Leung, Joyce Mak, Polly S Y Cheung, et al.
BMC Cancer|December 2, 2016
Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approachFrank P Y Lin, Adrian Pokorny, Christina Teng, et al.
Molecular Cancer Therapeutics|January 7, 2004
Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cellsYoon-Pin Lim, Lang-Shi Diong, Robert Qi, et al.
Molecular Carcinogenesis|December 18, 2015
Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoterJames Blackburn, Daniel L Roden, Robert Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugsYoon-Pin Lim, Chow Yin Wong, London Lucien Ooi, et al.
BMC Cancer|November 12, 2014
Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapyHilda Wong, Silvia Lau, Polly Cheung, et al.
JCO Clinical Cancer Informatics|October 20, 2022
Development and Validation of a Machine Learning Approach Leveraging Real-World Clinical Narratives as a Predictor of Survival in Advanced CancerFrank Po-Yen Lin, Osama S M Salih, Nina Scott, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysisJoanne Chiu, Vikki Tang, Roland Leung, et al.
Pageof 7